Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer-Reference-Cited by-同舟云学术

Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer

Published:2018-09-13 Issue:1 Volume:22 Page:66-76
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Murtola Teemu J.,Kasurinen Tatu V. J.,Talala Kirsi,Taari Kimmo,Tammela Teuvo L. J.,Auvinen Anssi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/s41391-018-0087-0.pdf

Reference42 articles.

1. Krycer JR, Brown AJ. Cholesterol accumulation in prostate cancer: a classic observation from a modern perspective. Biochim Biophys Acta. 2013;1835:219–29.

2. Di Vizio D, Solomon KR, Freeman MR. Cholesterol and cholesterol-rich membranes in prostate cancer: an update. Tumori. 2008;94:633–9.

3. Hager MH, Solomon KR, Freeman MR. The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care. 2006;9:379–85.

4. Zadra G, Photopoulos C, Loda M. The fat side of prostate cancer. Biochim Biophys Acta. 2013;1831:1518–32.

5. Gathirua-Mwangi WG, Zhang J. Dietary factors and risk for advanced prostate cancer. Eur J Cancer Prev. 2014;23:96–109.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between the metabolic score for insulin resistance and prostate cancer: a cross-sectional study in Xinjiang;PeerJ;2024-07-26

2. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and Prostate specific antigen (PSA): a cross-sectional study;2024-05-30

3. A Plant-Based Cholesterol-Lowering Diet Score Correlates with Serum LDL-Cholesterol Levels;Nutrients;2024-02-08

4. Low-Density Lipoprotein Cholesterol and Prostate Cancer: A Retrospective Study;Archivos Españoles de Urología;2024

5. The Impact of Atorvastatin on Intraprostatic Biomarkers – Prognostic Value of 3ls-Score – Follow-Up of Esto1-Trial;2024